Mechanistic Insights and International Use Cases of cTOT in Wound Management

Summary

This document provides an in-depth review of continuous topical oxygen therapy (cTOT) as an effective adjunctive treatment for managing chronic and complex wounds. ​ Chronic wounds, often caused by tissue hypoxia and impaired healing, are a growing global health concern. ​ cTOT delivers sustained oxygen directly to the wound bed, promoting cellular metabolism, immune modulation, angiogenesis, and tissue regeneration.

​Key Points:

  1. Mechanisms of cTOT:
    • Enhances mitochondrial ATP production, fibroblast and keratinocyte function, and collagen synthesis. ​
    • Promotes angiogenesis and extracellular matrix remodeling. ​
    • Facilitates the transition of macrophages from pro-inflammatory (M1) to reparative (M2) phenotypes. ​
    • Improves immune cell function and bactericidal efficacy. ​
  2. cTOT Device:
    • The NATROX® O₂ system delivers continuous low-pressure oxygen (11 ml/hour) via a portable, wearable device powered by rechargeable batteries. ​
    • Oxygen is delivered by the ODS, which is covered by a semi-occlusive dressing to maintain a wound healing environment.
  3. Clinical Applications:
    • cTOT has been successfully used to treat various hard-to-heal wounds around the world, including diabetic foot ulcers (DFUs), vasculitis, burns, open amputation sites, calciphylaxis, surgical dehiscence, and osteoradionecrosis.
    • Eight international case studies from six countries (USA; Colombia; Portugal; UK; Malaysia; South Africa) demonstrated significant clinical improvement, with complete wound closure achieved in all cases. ​Healing timelines ranged from 4 to 29 weeks. ​
  4. Global Relevance:
    • Chronic wounds affect over 13 million people worldwide, with prevalence expected to rise due to aging populations and associated comorbidities. ​
    • cTOT has been integrated into standard care protocols globally and is supported by evidence from randomized controlled trials and systematic reviews.

Conclusion:

cTOT is a promising, globally adaptable therapy for chronic and complex wounds. ​It addresses physiological barriers to healing and complements standard of care protocols. ​Further research is needed to optimize treatment protocols, identify ideal patient subgroups, and evaluate long-term outcomes.

​The document highlights the transformative potential of cTOT in wound care, emphasizing its ability to improve healing outcomes across diverse wound types and healthcare settings. ​

Citation:

Windy Cole, Harikrishna KR Nair, Sagar U Nigwekar, Viviana Gonçalves, Liezl Naude, Wolmark Xiques Molina, Noel B Natoli, Andrew Camilleri

22 December 2025